Sosei Appoints David Chiswell as Non-Executive Chairman
Sosei Co. Ltd. announced the appointment of Dr. David Chiswell as Non-Executive Chairman.
David Chiswell was a founder and, from 1996 to 2002, the CEO of Cambridge Antibody Technology (CAT). Currently David is Chairman of the UK's BioIndustry Association (BIA). In addition, he is Chairman of Arrow Therapeutics Ltd and a non-executive director of Arakis Ltd. David is also an advisor to a number of private equity funds including Nomura Phase 4 Ventures. His previous experience was gained with Amersham International as well as within research posts at various institutions including the Medical Research Council, UCLA and the Imperial Cancer Research Fund.
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.